• FirefoxInstall the new Firefox »
  •  Dow Down 1.11% Nasdaq Down 0.94%

    Delcath Systems, Inc. (DCTH)

    -NasdaqCM
    0.96 Mar 31, 3:59PM EDT
    Add to Portfolio
    Prev Close:0.96
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:1.30
    Beta:1.41
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.92 - 4.96
    Volume:0
    Avg Vol (3m):131,513
    Market Cap:9.32M
    P/E (ttm):N/A
    EPS (ttm):-1.84
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for DCTH

    Comparison

    Symbol% ChgMkt Cap
    DCTH 0.00%9.32M
    LLY77.05B
    ONXXN/A
    PFE213.22B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.72
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:4.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback